DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Funds early-stage breast cancer research aimed at a future breakthrough, before the work is mature enough for a clinical trial.
Breast cancer research keeps stalling at the same point: an idea looks promising in the lab, but nobody has the money to push it toward something a patient could actually use. This award exists for exactly that gap, at its earliest stage.
It funds Breast Cancer Research Program work under Funding Level 1 or Funding Level 2, and every application has to address at least one of the FY26 BCRP's own …
Early-stage breast cancer research under BCRP Funding Level 1 or Level 2, addressing at least one FY26 BCRP overarching challenge and aimed at work that could lead to a future clinical breakthrough. Level 2 includes a Population Science Studies option that can request additional funding and time. No clinical trial is involved at this stage.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up